The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis

BACKGROUND: In chronic diseases such as multiple sclerosis requiring lifelong treatment, studies on long-term outcomes are important. OBJECTIVE: To assess disability and magnetic resonance imaging-related outcomes in relapsing multiple sclerosis patients from a Phase 2 study of fingolimod 10 or more...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mult Scler J Exp Transl Clin
Asıl Yazarlar: Derfuss, T, Sastre-Garriga, J, Montalban, X, Rodegher, M, Wuerfel, J, Gaetano, L, Tomic, D, Azmon, A, Wolf, C, Kappos, L
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2020
Konular:
Original Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7132565/
https://ncbi.nlm.nih.gov/pubmed/32284874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320907951
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller